• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兰州布鲁氏菌泄露事件:传染病史上最大的实验室事故?

The Lanzhou Brucella Leak: The Largest Laboratory Accident in the History of Infectious Diseases?

机构信息

Institute of Continuing Medical Education of Ioannina, Ioannina, Greece.

出版信息

Clin Infect Dis. 2022 Nov 14;75(10):1845-1847. doi: 10.1093/cid/ciac463.

DOI:10.1093/cid/ciac463
PMID:35675697
Abstract

An inadequacy in sanitizing processes in a biopharmaceutical plant in Lanzhou, China, during July and August 2019, led to the aerosolization of Brucella that was subsequently spread through wind to nearby settlements and academic institutes, resulting in >10 000 human brucellosis cases, as of November 2020. The leak, possibly the largest laboratory accident in the history of infectious diseases, underlines the particular characteristics of Brucella that have made the pathogen a historical entity in biodefense research and a major cause of laboratory-associated infections. It further underlines the need for enhanced vigilance and strict regulatory interventions in similar facilities.

摘要

2019 年 7 月至 8 月,中国兰州一家生物制药厂的消毒过程存在缺陷,导致布鲁氏菌气溶胶化,随后通过风传播到附近的定居点和学术机构,截至 2020 年 11 月,导致超过 10000 例人类布鲁氏菌病病例。此次泄漏事件可能是传染病史上最大的实验室事故,突显了布鲁氏菌的特殊特征,使其成为生物防御研究中的历史实体,也是实验室相关感染的主要原因。它进一步强调了在类似设施中加强警惕和严格监管干预的必要性。

相似文献

1
The Lanzhou Brucella Leak: The Largest Laboratory Accident in the History of Infectious Diseases?兰州布鲁氏菌泄露事件:传染病史上最大的实验室事故?
Clin Infect Dis. 2022 Nov 14;75(10):1845-1847. doi: 10.1093/cid/ciac463.
2
Exposure Risk Events in 10 Clinical Laboratories, New York City, USA, 2015 to 2017.2015 至 2017 年美国纽约市 10 家临床实验室的暴露风险事件。
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01096-19.
3
Biochemical mis-identification of Brucella melitensis and subsequent laboratory-acquired infections.羊种布鲁氏菌的生化误鉴定及随后的实验室获得性感染。
J Hosp Infect. 1992 Oct;22(2):159-62. doi: 10.1016/0195-6701(92)90100-z.
4
Correction to: The Lanzhou Brucella Leak: The Largest Laboratory Accident in the History of Infectious Diseases?对《兰州布鲁氏菌泄漏事件:传染病史上最大的实验室事故?》的更正
Clin Infect Dis. 2023 Apr 3;76(7):1347. doi: 10.1093/cid/ciac806.
5
Molecular investigation of infection sources and transmission chains of brucellosis in Zhejiang, China.中国浙江布鲁氏菌病感染源和传播链的分子调查。
Emerg Microbes Infect. 2020 Dec;9(1):889-899. doi: 10.1080/22221751.2020.1754137.
6
Outbreak of laboratory-acquired Brucella abortus in Brazil: a case report.巴西暴发实验室感染布鲁氏菌流产亚种:病例报告。
Rev Soc Bras Med Trop. 2013 Nov-Dec;46(6):791-4. doi: 10.1590/0037-8682-0160-2013.
7
Laboratory-acquired brucellosis.实验室获得性布鲁氏菌病
J Hosp Infect. 1989 Jul;14(1):69-71. doi: 10.1016/0195-6701(89)90136-9.
8
Brucellosis in the UK: a risk to laboratory workers? Recommendations for prevention and management of laboratory exposure.英国的布鲁氏菌病:对实验室工作人员的风险?实验室接触的预防和管理建议。
J Clin Pathol. 2010 Jan;63(1):90-2. doi: 10.1136/jcp.2007.053108. Epub 2008 May 21.
9
Review of clinical and laboratory features of human brucellosis.人类布鲁氏菌病的临床及实验室特征综述。
Indian J Med Microbiol. 2007 Jul;25(3):188-202. doi: 10.4103/0255-0857.34758.
10
[Investigation of Brucella canis Seroprevalence in Brucellosis Suspected Cases].[疑似布鲁氏菌病病例中犬种布鲁氏菌血清阳性率调查]
Mikrobiyol Bul. 2013 Jan;47(1):152-7. doi: 10.5578/mb.4417.

引用本文的文献

1
A Family Cluster of Imported Human Infection with Probable Breast Milk Transmission: A Case Series.一起可能通过母乳传播的输入性人类感染家庭聚集病例系列报道
Trop Med Infect Dis. 2025 Aug 14;10(8):227. doi: 10.3390/tropicalmed10080227.
2
A scoping review on the epidemiology and public significance of in Chinese dairy cattle and humans.关于中国奶牛和人类中[具体内容缺失]的流行病学及公共意义的范围综述。
One Health. 2024 Jan 26;18:100683. doi: 10.1016/j.onehlt.2024.100683. eCollection 2024 Jun.
3
Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2022.
2022年加拿大实验室人员接触人类病原体和毒素情况监测
Can Commun Dis Rep. 2023 Sep 1;49(9):398-405. doi: 10.14745/ccdr.v49i09a06.
4
The Reasons Behind Long-Term Endemicity of Brucellosis in Low and Middle-Income Countries: Challenges and Future Perspectives.布鲁氏菌病在中低收入国家长期流行的原因:挑战与未来展望。
Curr Microbiol. 2024 Jan 30;81(3):82. doi: 10.1007/s00284-023-03605-5.
5
Evaluating the long-term impact of COVID-19-associated public health interventions on zoonotic and vector-borne diseases in China: an interrupted time series analysis.评估 COVID-19 相关公共卫生干预措施对中国动物源性和媒介传播疾病的长期影响:一项中断时间序列分析。
J Transl Med. 2024 Jan 20;22(1):81. doi: 10.1186/s12967-024-04855-y.
6
What risk do Brucella vaccines pose to humans? A systematic review of the scientific literature on occupational exposure.布鲁氏菌疫苗对人类有哪些风险?职业暴露科学文献的系统综述。
PLoS Negl Trop Dis. 2024 Jan 8;18(1):e0011889. doi: 10.1371/journal.pntd.0011889. eCollection 2024 Jan.
7
A review of coxiellosis (Q fever) and brucellosis in goats and humans: Implications for disease control in smallholder farming systems in Southeast Asia.山羊和人类的柯克斯体病(Q热)及布鲁氏菌病综述:对东南亚小农户养殖系统疾病控制的启示
One Health. 2023 May 22;16:100568. doi: 10.1016/j.onehlt.2023.100568. eCollection 2023 Jun.
8
Follow-up outcomes of asymptomatic brucellosis: a systematic review and meta-analysis.无症状布鲁氏菌病的随访结局:系统评价和荟萃分析。
Emerg Microbes Infect. 2023 Dec;12(1):2185464. doi: 10.1080/22221751.2023.2185464.
9
Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis.激活黏膜免疫作为对抗布鲁氏菌病的一种新型治疗策略。
Front Microbiol. 2022 Dec 22;13:1018165. doi: 10.3389/fmicb.2022.1018165. eCollection 2022.
10
Bioaerosol dispersion and environmental risk simulation: Method and a case study for a biopharmaceutical plant of Gansu province, China.生物气溶胶扩散与环境风险模拟:以中国甘肃省某生物制药厂为例的方法研究
Sci Total Environ. 2023 Feb 20;860:160506. doi: 10.1016/j.scitotenv.2022.160506. Epub 2022 Nov 25.